How much funding has Neurotrack raised?

Neurotrack has raised $43.3M in total funding, most recently a Series C round.

Who are Neurotrack's investors?

Neurotrack's investors include Founders Fund, Social Capital, Khosla Ventures, Sozo Ventures, AME Cloud Ventures, Dai-ichi Life.

When was Neurotrack founded?

Neurotrack was founded in 2012.

Where is Neurotrack headquartered?

Neurotrack is headquartered in Redwood City, California, United States.

How many employees does Neurotrack have?

Neurotrack has 11-50 employees.

Neurotrack

Q: What industry is Neurotrack in?

Neurotrack operates in Digital Health, Healthcare, Data & Analytics, Artificial Intelligence, Biotech.

Neurotrack Cognitive Function Test: Assess for MCI, Dementia, Alzheimer

Redwood City, United States · Founded 2012 · $43.3M raised

Digital Health

Healthcare

Data & Analytics

Artificial Intelligence

Biotech

Headquarters: Redwood City, California
Employees: 11–50
Founded: 2012
Business Model: B2B

Website: neurotrack.com
Total Funding: $43.3M
Last Round: $21.0M Series CJun 2019
Rounds: 5

About

Neurotrack develops FDA-registered digital cognitive screening tools that help clinicians detect mild cognitive impairment (MCI) and early-stage dementia in as little as 3 minutes. Its platform integrates with all major EHRs, is SOC 2- and HIPAA-compliant, and is used by over 15,000 providers across leading health systems, home health, and primary care settings. Neurotrack's technology is backed by 375+ peer-reviewed publications and funded by the NIA and Gates Foundation.

Summary

Neurotrack is a Digital Health company based in Redwood City, United States, founded in 2012. It has raised $43.3M in total across 5 rounds, most recently a $21.0M Series C round in Jun 2019. Investors include Founders Fund, Social Capital and Khosla Ventures.

LinkedIn X (Twitter)